In 2020, the Japanese generics drug market was estimated to value at approximately 1.6 trillion Japanese yen, increased significantly from about 457 billion yen in 2005. Since the government started to promote the use of generics in 2007, the generics market showed constant growth for a decade until the recent stagnation.
Estimated value of the generics drug market in Japan from 2005 to 2020 (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
- Basic Statistic Sawai Pharmaceutical's sales revenue FY 2012-2021
- Premium Statistic Major drug manufacturers Japan 2017, by number of products
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2022
- Premium Statistic Sawai Pharmaceutical's employee numbers 2012-2021
- Premium Statistic Share of prescription drug market Japan 2010-2019 , by category
- Premium Statistic Prescription drug market sales share of generics 2008-2019
- Basic Statistic Nichi-Iko's sales revenue FY 2012-2021
- Premium Statistic Prescription drug market sales share of LLPs Japan 2008-2019
- Premium Statistic Nichi-Iko's sales share of generics in Japan FY 2012-2021
About the region
10
- Premium Statistic Major drug manufacturers Japan FY 2020, by wholesalers' sales share
- Premium Statistic Volume share of generics in prescription drug market Japan 2005-2022
- Premium Statistic Sawai Pharmaceutical's total assets FY 2011-2020
- Premium Statistic Meiji's food segment net sales FY 2022, by business
- Premium Statistic Sawai Pharmaceutical's R&D expenditure FY 2012-201
- Premium Statistic Sawai Pharmaceutical patent numbers FY 2012-2021
- Premium Statistic Sawai Pharmaceutical's net income FY 2012-2021
- Basic Statistic Takeda Pharmaceutical's revenue FY 2013-2022
- Premium Statistic Prescription drug market sales share of original drugs 2008-2019
- Premium Statistic Takeda Pharmaceutical's expenditure on R&D FY 2011-2020
Selected statistics
10
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Basic Statistic Merck & Co total assets 2009-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
8
- Premium Statistic Veterinary reference laboratories market size U.S. by animal type 2015-2025
- Basic Statistic Export value of pharmaceuticals from Sweden 2012-2022
- Premium Statistic Latin America: main pharmacies 2017, by number of stores
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic HAL sales turnover FY 2014-2023
- Premium Statistic Pharmacy sales in Brazil 2014-2021
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Main pharmacies in Mexico 2019, by size
Related statistics
10
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Takeda Pharmaceutical's revenue in FY 2016, by segment
- Premium Statistic Astellas Pharma's net profit FY 2013-2022
- Premium Statistic Production value of medical devices Japan 2012-2021
- Premium Statistic Companies with the highest number of pharmaceutical patent applications Japan 2022
- Basic Statistic Fuji Pharma's net sales FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's revenue breakdown FY 2022, by region
- Premium Statistic Takeda Pharmaceutical's net income FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's number of employees FY 2013-2022
Further related statistics
10
- Pfizer's ad spending 2008-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- John Lewis sales revenue in the United Kingdom (UK) 2009-2023
- Waitrose sales revenue in the United Kingdom (UK) 2009-2023
- Global net sales of Monster Beverage 2008-2022
- Revenue of the Bank of Communications 2022
- Total revenue of Prudential Financial 2006-2022
- Net revenue from investment banking at Goldman Sachs 2009-2022
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2008-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- John Lewis sales revenue in the United Kingdom (UK) 2009-2023
- Waitrose sales revenue in the United Kingdom (UK) 2009-2023
- Global net sales of Monster Beverage 2008-2022
- Revenue of the Bank of Communications 2022
- Total revenue of Prudential Financial 2006-2022
- Net revenue from investment banking at Goldman Sachs 2009-2022
Shared Research. (June 6, 2022). Estimated value of the generics drug market in Japan from 2005 to 2020 (in billion Japanese yen) [Graph]. In Statista. Retrieved December 01, 2023, from https://www.statista.com/statistics/801562/japan-generics-drug-market-sales-revenue/
Shared Research. "Estimated value of the generics drug market in Japan from 2005 to 2020 (in billion Japanese yen)." Chart. June 6, 2022. Statista. Accessed December 01, 2023. https://www.statista.com/statistics/801562/japan-generics-drug-market-sales-revenue/
Shared Research. (2022). Estimated value of the generics drug market in Japan from 2005 to 2020 (in billion Japanese yen). Statista. Statista Inc.. Accessed: December 01, 2023. https://www.statista.com/statistics/801562/japan-generics-drug-market-sales-revenue/
Shared Research. "Estimated Value of The Generics Drug Market in Japan from 2005 to 2020 (in Billion Japanese Yen)." Statista, Statista Inc., 6 Jun 2022, https://www.statista.com/statistics/801562/japan-generics-drug-market-sales-revenue/
Shared Research, Estimated value of the generics drug market in Japan from 2005 to 2020 (in billion Japanese yen) Statista, https://www.statista.com/statistics/801562/japan-generics-drug-market-sales-revenue/ (last visited December 01, 2023)
Estimated value of the generics drug market in Japan from 2005 to 2020 (in billion Japanese yen) [Graph], Shared Research, June 6, 2022. [Online]. Available: https://www.statista.com/statistics/801562/japan-generics-drug-market-sales-revenue/